Author

D. B. Watson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Approach:statistical model· 1

Frequent Co-Authors

T. Alban· 2 shared A. Jimenez-Pascual· 1 shared A. Kordowski· 1 shared A. Lauko· 1 shared A. Rabljenovic· 1 shared A. Steffens· 1 shared A. Zalavadia· 1 shared B. Otvos· 1 shared

Activity by Year

2019-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

T. Alban

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The MIF SNP rs755622 is a germline determinant of tumor immune activation in Glioblastoma

T. Alban, M. M. Grabowski, B. Otvos, D. B. Watson, A. Zalavadia, V. Makarav, K. M. Troike, M. McGraw, A. Rabljenovic, A. Lauko, C. K. A. Neumann, G. Roversi, K. Waite, G. Cioffi, N. Patil, , J. Lathia

The paper identifies a germline SNP, rs755622, associated with increased leukocyte infiltration in glioblastoma and links it to lactotransferrin expression as a potential biomarker for immune activation.

bioRxiv · Mar 7, 2022 · PreprintCancer Biology

ADAMDEC1 maintains a novel growth factor signaling loop in cancer stem cells

J. S. Hale, A. Jimenez-Pascual, A. Kordowski, J. Pugh, S. Rao, D. J. Silver, T. Alban, D. B. Watson, R. Chen, T. M. McIntyre, G. Colombo, G. Taraboletti, K. O. Holmberg, K. Forsberg-Nilsson, J. D. Lathia, F. Siebzehnrubl

This study identifies a novel signaling loop involving ADAMDEC1 and FGF2/FGFR1 that maintains glioblastoma cancer stem cells and shows targeting this loop reduces tumor growth.

bioRxiv · Jan 26, 2019Cancer Biology